Skip to content

Latest

New Novartis app enhances opthalmology trials

New Novartis app enhances opthalmology trials

Novartis has launched the FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients.

CVS releases 11th annual CSR Report

CVS releases 11th annual CSR Report

CVS Health  today released its 11th annual Corporate Social Responsibility (CSR) Report, detailing its latest efforts to shape the future of health care, reduce environmental impact and exemplify corporate leadership in fulfilling the company’s purpose of helping people on their path to better healt

Avella to improve access to Naloxone

Avella to improve access to Naloxone

Avella has announced it will distribute naloxone, a powerful therapy used to treat opioid overdoses, as part of an innovative new program designed to improve access to the drug.

NACDS Foundation announces scholarships, grants

NACDS Foundation announces scholarships, grants

PALM BEACH, Fla. –The NACDS Foundation has distributed $220,000 in scholarships and grants as part of an ongoing commitment to advancing patient care through pharmacy education as part of the 23rd Annual NACDS Foundation Scholarship Program.

Lupin gets FDA approval for generic Xenazine tablets

Lupin gets FDA approval for generic Xenazine tablets

Lupin announced today that it has received final approval for its Tetrabenazine tablets, 12.5 mg and 25 mg from the United States Food and Drug Administration (FDA) to market a generic version of Valeant Pharmaceuticals North America’s  Xenazine tablets, 12.5 mg and 25 mg.

NACDS names new officers, board members

NACDS names new officers, board members

PALM BEACH, Fla. –  The National Association of Chain Drug Stores has elected new officers, and executive committee and board  members for the coming year. The appointments were announced at the NACDS Annual Meeting.